Cargando…
β cell replacement therapy for the cure of diabetes
Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant‐related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623521/ https://www.ncbi.nlm.nih.gov/pubmed/35818819 http://dx.doi.org/10.1111/jdi.13884 |
_version_ | 1784822014841716736 |
---|---|
author | Lee, Joonyub Yoon, Kun‐Ho |
author_facet | Lee, Joonyub Yoon, Kun‐Ho |
author_sort | Lee, Joonyub |
collection | PubMed |
description | Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant‐related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy. |
format | Online Article Text |
id | pubmed-9623521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96235212022-11-02 β cell replacement therapy for the cure of diabetes Lee, Joonyub Yoon, Kun‐Ho J Diabetes Investig Mini Review Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant‐related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy. John Wiley and Sons Inc. 2022-07-29 2022-11 /pmc/articles/PMC9623521/ /pubmed/35818819 http://dx.doi.org/10.1111/jdi.13884 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Mini Review Lee, Joonyub Yoon, Kun‐Ho β cell replacement therapy for the cure of diabetes |
title | β cell replacement therapy for the cure of diabetes |
title_full | β cell replacement therapy for the cure of diabetes |
title_fullStr | β cell replacement therapy for the cure of diabetes |
title_full_unstemmed | β cell replacement therapy for the cure of diabetes |
title_short | β cell replacement therapy for the cure of diabetes |
title_sort | β cell replacement therapy for the cure of diabetes |
topic | Mini Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623521/ https://www.ncbi.nlm.nih.gov/pubmed/35818819 http://dx.doi.org/10.1111/jdi.13884 |
work_keys_str_mv | AT leejoonyub bcellreplacementtherapyforthecureofdiabetes AT yoonkunho bcellreplacementtherapyforthecureofdiabetes |